The present invention relates to compounds of formula (I) ##STR1## wherein U, Y, V, W, L, X, A.sup.1, A.sup.2, A.sup.3, A.sup.4, A.sup.5 and A.sup.6 are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, and/or treatment and/or prophylaxis of impaired glucose tolerance and diabetes.

Присытствыющий вымысел относит к смесям ## ## STR1 формулы (I) при котором у, ы, в, ш, л, х, A.sup.1, A.sup.2, A.sup.3, A.sup.4, A.sup.5 и A.sup.6 как определено в описании и заявках и фармацевтически приемлемо солях and/or фармацевтически приемлемо эстерах thereof. Смеси полезны для обработки and/or профилактирования заболеваний связаны с cyclase 2,3-oxidosqualene-lanosterol such as hypercholesterolemia, hyperlipemia, артериосклероз, васкулярные заболевания, mycoses, инфекции дармоеда, gallstones, туморы and/or hyperproliferative разлады, and/or обработки and/or профилактирования поврежденных допуска и мочеизнурения глюкозы.

 
Web www.patentalert.com

< Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders

< Anti-first-pass effect compounds

> P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use

> EP4 receptor selective agonists in the treatment of osteoporosis

~ 00098